Cesca Therapeutics Inc. (KOOL) financial statements (2021 and earlier)

Company profile

Business Address 2711 CITRUS ROAD
RANCHO CORDOVA, CA 95742
State of Incorp. DE
Fiscal Year End December 31
SIC 3821 - Laboratory Apparatus and Furniture (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments32463157
Cash and cash equivalents32463157
Receivables1243555
Inventory, net of allowances, customer advances and progress billings4444564
Inventory4444564
Prepaid expense and other current assets0
Other undisclosed current assets200000 
Total current assets:1091113132516
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment2323322
Intangible assets, net (including goodwill)2233343435
Goodwill1113131313 
Intangible assets, net (excluding goodwill)1220212122 
Restricted cash and investments 1     
Other noncurrent assets000000
Prepaid expense and other noncurrent assets0
Total noncurrent assets:56363738382
TOTAL ASSETS:15154750516319
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities2323644
Accounts payable1223543
Employee-related liabilities0100110
Deferred revenue1
Due to related parties  1    
Deferred revenue and credits11110
Contract with customer, liability0
Other liabilities2112221
Other undisclosed current liabilities22     
Total current liabilities:7656865
Noncurrent Liabilities
Long-term debt and lease obligation2  2   
Long-term debt, excluding current maturities1  2   
Operating lease, liability1
Liabilities, other than long-term debt521210880
Deferred revenue and credits    0
Deferred revenue2
Deferred tax liabilities, net 7888 
Due to related parties414    
Other liabilities0001000
Derivative instruments and hedges, liabilities 011   
Other undisclosed noncurrent liabilities0      
Total noncurrent liabilities:821212880
Total liabilities:148161816145
Stockholders' equity
Stockholders' equity attributable to parent083132354913
Common stock0000000
Additional paid in capital237236216189173171127
Accumulated other comprehensive income (loss)0(0)(0)(0)(0)0 
Accumulated deficit(237)(227)(185)(156)(138)(123)(114)
Stockholders' equity attributable to noncontrolling interest1(2)     
Total stockholders' equity:173132354913
TOTAL LIABILITIES AND EQUITY:15154750516319

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Revenues13101512161618
Revenue, net1512161618
Cost of revenue(7)(7)(9)(9)(11)(10)(12)
Cost of goods and services sold(7)(7)     
Other undisclosed gross profit    (0)  
Gross profit:6263566
Operating expenses(10)(46)(15)(14)(20)(15)(9)
Operating loss:(5)(44)(9)(11)(15)(9)(3)
Nonoperating income (expense)(0)(0)(21)(8) 0(0)
Other nonoperating income (expense)(0)(0)0(0)   
Interest and debt expense(5)(3)(11)(1)   
Loss from continuing operations before equity method investments, income taxes:(10)(46)(40)(19)(15)(9)(3)
Loss from equity method investments(0)      
Other undisclosed income from continuing operations before income taxes0111 0  
Loss from continuing operations before income taxes:(10)(46)(30)(19)(15)(9)(3)
Income tax benefit 51  0 
Net loss:(10)(41)(29)(19)(15)(9)(3)
Net income attributable to noncontrolling interest11     
Other undisclosed net income attributable to parent   1   
Net loss available to common stockholders, diluted:(9)(40)(29)(19)(15)(9)(3)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
6/30/2013
Net loss:(10)(41)(29)(19)(15)(9)(3)
Other undisclosed comprehensive income00     
Comprehensive loss:(10)(41)(29)(19)(15)(9)(3)
Comprehensive income, net of tax, attributable to noncontrolling interest11     
Other undisclosed comprehensive income (loss), net of tax, attributable to parent  (0)1(0)0 
Comprehensive loss, net of tax, attributable to parent:(9)(40)(29)(19)(15)(9)(3)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: